Cryopreservation of cord blood after liquid storage

References

• Ballen K, Broxmeyer HE, McCullough J et al. Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001;7:635–45.
   PubMedGoogle Scholar
• Hows JM. Status of umbilical cord blood transplantation in theyear 2001. 7 Clin Pathol 2001;54:428— 34.
   PubMedGoogle Scholar
• Stanworth S, Warwick R, Fehily D et al. An international surveyof unrelated umbilical cord blood banking. Vox Sang 2001;80:236–43.
   PubMedGoogle Scholar
• Rebulla P. Cord blood banking 2002: 112,010 of 7,914,773 chances. Transfusion 2002;42:1246— 8.
   PubMedGoogle Scholar
• Shlebak AA, Marley SB, Roberts IA et al. Optimal timing for processing and cryopreservation of umbilical cord haemato-poietic stem cells for clinical transplantation. Bone Marrow Transplant 1999;23:131 — 6.
   PubMedGoogle Scholar
• Rogers I, Sutherland D, Holt D et al. Human UC-blood banking impact of blood volume, cell separation and cryopreservation on leukocyte and CD34± recovery. Cytotherapy 2001;3:269— 76.
   PubMedGoogle Scholar
• Beaujean F Pico J, Norol F et al. Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage. Hematother 1996;5:681— 6.
   PubMedGoogle Scholar
• Ciavarella D. Hematopoietic stem cell processing and storage. Biotechnology 1991;19:317–49.
   PubMedGoogle Scholar
• de Kreuk AM, Jonkhoff AR, Zevenbergen A et al. Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days. Bone Marrow Transplant 2001;28:145— 55.
   PubMed Web of Science ®Google Scholar
• Kohsaki M, Yanes B, Ungerleider JS, Murphy MJ, Jr. Non-frozenpreservation of committed hematopoietic stem cells from normal human bone marrow. Stem Cells 1981;1:111–23.
   Google Scholar
• Lasky LC. Liquid storage of unseparated human bone marrow:evaluation of hematopoietic progenitors by clonal assay. Trans-fusion 1986;26:331 — 4.
   PubMedGoogle Scholar
• Mangalik A, Robinson WA, Drebing C et al. Liquid storage of bone marrow. Exp Hematol 1979;7:76–94.
   PubMed Web of Science ®Google Scholar
• Wells JR, Cline MJ. Preservation of granulopoietic precursors innonfrozen, stored human bone marrow. Transplantation 1996;22:568— 71.
   Google Scholar
• Ager S, Mahendra P, Jestice HK et al. The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantation. Bone Marrow Transplant 1995;16:633–4.
   PubMed Web of Science ®Google Scholar
• Bezwoda WR, Dansey R, Seymour L, Glencross D. Non-cryopreserved, limited number (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administra-tion provide adequate hematologic support for high dose chemotherapy. Hematol Oncol 1994;12:101— 10.
   PubMedGoogle Scholar
• Jestice HK, Scott MA, Ager S et al. Liquid storage of peripheral blood progenitor cells for transplantation. Bone Marrow Trans-plant 1994;14:991— 4.
   PubMedGoogle Scholar
• Jones N, Williams D, Broadbent V et al. High-dose melphalan followed by autograft employing non-cryopreserved peripheral blood progenitor cells in children. Eur y Cancer 1996;32A:1938–42.
   PubMedGoogle Scholar
• Ruiz-Arguelles GJ, Ruiz-Arguelles A, Perez-Romano B et al. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am 7 Hematol 1995;48: 100— 3.
   Google Scholar
• Burger SR, Hubel A, McCullough J. Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storage. Cytotherapy 1999;1:123— 33.
   Google Scholar
• Schmid J, McCullough J, Burger SR, Hubel A. Non-cryopre-served bone marrow storage in STM-Sav, in infusible-grade cell storage solution. Cell Preserv Technol 2002;1:45— 52.
   Google Scholar
• Hubel A, Carlquist D, Clay M, McCullough J. Short term liquidstorage of umbilical cord blood. Transfusion 2003;43:626— 32.
   PubMedGoogle Scholar
• Mascotti K. Hematopoietic progenitor cell viability measure-ment: Trypan blue versus acridine orange/propidium iodide. Transfusion 2000;40:693 —6.
   PubMedGoogle Scholar
• Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34± cell determination by flow cytometry. [International Society of Hematotherapy and Graft Engineer-ing]. y Hematother 1996;5:213 — 26.
   Google Scholar
• Burger SR, Kadidlo D, McCullough J. Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony stimulating factor. Transfusion 1999;39:451— 6.
   Google Scholar
• Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320— 5.
   PubMedGoogle Scholar